Stevanato Group S.p.A (STVN) Other Non-Current Assets (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Other Non-Current Assets came in at $7.5 million in Q1 2026, down 49.76% year-on-year from $14.9 million in Q1 2025, and up 10.91% on a QoQ basis from $6.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Other Non-Current Assets data on file, last reported at $7.5 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 49.76% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 49.76% decrease from a year earlier, with the FY2025 full-year figure at $6.8 million, up 17.2% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $7.5 million, up from $6.8 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for STVN reached as high as $15.6 million in Q3 2025 and fell as low as $920554.5 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $6.4 million across 5 years, with a median of $6.0 million in 2024.
- Across the five-year window, Other Non-Current Assets tumbled 84.39% in 2022 and surged 559.26% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.0 million in 2022, then soared by 374.56% to $4.8 million in 2023, then grew by 19.18% to $5.8 million in 2024, then grew by 17.2% to $6.8 million in 2025, then gained by 10.91% to $7.5 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $7.5 million in Q1 2026, $6.8 million in Q4 2025, and $15.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | 7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 6.76 Mn |
| Sep 30, 2025 | 15.60 Mn |
| Jun 30, 2025 | 15.19 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 6.16 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 920,554.46 |
| Jun 30, 2022 | 961,418.08 |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 5.90 Mn |
| Jun 30, 2021 | 3.15 Mn |